CSPC Pharma wins China NMPA clearance to start Phase 1 trial of SYH2092 obesity drugPUBT·6 hours ago01093-3.04%
Sino Biopharma licenses HER2 ADC TQB2102 to Cipla for India, South Africa, other emerging markets in deal worth up to USD 123 millionPUBT·7 hours ago01177-2.59%
STOCKS | Lenovo Tops Hang Seng China Enterprises Index Gainers In Month, Kuaishou LagsCoinLive·9 hours agoLNVGY+0.93%SHZHY-3.12%
D Bkg Cuts AKESO TP to HKD127 as Interim Results Miss ExpectationsAASTOCKS News·9 hours ago09926-5.72%
CLSA Raises HANSOH PHARMA TP to HKD43.7, 1H Results Beat ExpectationsAASTOCKS News·10 hours ago03692-3.76%
STOCKS | InnoCare Bio-B Falls More Than 10% Before Narrowing LossesCoinLive·15 hours agoBGNE0.00%WXXWY-3.17%
Weekly Recap | AKESO +7.92%, ivonescimab Phase III hits endpointWeekly Review·2 days ago, 12:06 AM09926-5.72%
